Header Logo

Sheila Dowd

Concepts (78)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Phobia, Social
4
2023
12
0.760
 Why?
Cycloserine
5
2023
25
0.710
 Why?
Implosive Therapy
4
2023
16
0.610
 Why?
Transcranial Magnetic Stimulation
6
2015
15
0.410
 Why?
Depressive Disorder, Major
4
2015
98
0.350
 Why?
Antimetabolites
3
2019
13
0.330
 Why?
Clonazepam
3
2003
25
0.310
 Why?
Treatment Outcome
10
2023
3292
0.220
 Why?
Flunitrazepam
1
2002
1
0.210
 Why?
Substance Abuse Treatment Centers
1
2002
2
0.210
 Why?
GABA Modulators
1
2002
4
0.210
 Why?
Rape
1
2002
5
0.210
 Why?
Anti-Anxiety Agents
1
2002
37
0.200
 Why?
Antibiotics, Antitubercular
1
2020
2
0.180
 Why?
Adult
12
2021
7351
0.150
 Why?
Antidepressive Agents
2
2015
93
0.150
 Why?
Extinction, Psychological
3
2023
12
0.140
 Why?
Electroconvulsive Therapy
3
2007
16
0.140
 Why?
Double-Blind Method
4
2020
398
0.130
 Why?
Depressive Disorder, Treatment-Resistant
1
2015
9
0.130
 Why?
Panic Disorder
1
2016
129
0.130
 Why?
Humans
16
2023
25967
0.120
 Why?
Depressive Disorder
2
2007
167
0.110
 Why?
Combined Modality Therapy
3
2023
277
0.110
 Why?
Phobic Disorders
1
2013
64
0.110
 Why?
Behavior Therapy
1
2013
81
0.100
 Why?
Sleep Wake Disorders
1
2013
102
0.100
 Why?
Fear
2
2023
43
0.100
 Why?
Anxiety Disorders
2
2023
157
0.100
 Why?
Female
11
2020
14351
0.100
 Why?
Male
10
2020
13984
0.090
 Why?
Middle Aged
9
2016
8508
0.080
 Why?
Psychiatric Status Rating Scales
4
2013
304
0.070
 Why?
Placebos
2
2020
66
0.070
 Why?
Anticonvulsants
2
2007
54
0.070
 Why?
Attention
2
2003
126
0.060
 Why?
Substance Abuse Detection
1
2003
5
0.050
 Why?
Severity of Illness Index
2
2020
929
0.050
 Why?
Electric Stimulation
1
2003
48
0.050
 Why?
Forensic Medicine
1
2002
1
0.050
 Why?
Hair
1
2002
3
0.050
 Why?
Anxiety
1
2023
135
0.050
 Why?
Pilot Projects
2
2015
375
0.050
 Why?
Recurrence
2
2015
306
0.050
 Why?
Memory
1
2002
300
0.040
 Why?
Cognition Disorders
2
2007
986
0.040
 Why?
Young Adult
2
2016
1848
0.040
 Why?
Drug Administration Schedule
1
2020
156
0.040
 Why?
Galvanic Skin Response
1
2019
6
0.040
 Why?
Photic Stimulation
1
2019
32
0.040
 Why?
Placebo Effect
1
2019
19
0.040
 Why?
Mental Recall
1
2019
67
0.040
 Why?
Case-Control Studies
1
2020
546
0.040
 Why?
Prospective Studies
2
2015
1646
0.040
 Why?
Time Factors
2
2015
1361
0.030
 Why?
Retreatment
1
2015
8
0.030
 Why?
Watchful Waiting
1
2015
9
0.030
 Why?
Drug Resistance
1
2015
42
0.030
 Why?
Feasibility Studies
1
2015
202
0.030
 Why?
Gas Chromatography-Mass Spectrometry
2
2003
13
0.030
 Why?
Predictive Value of Tests
1
2013
457
0.020
 Why?
Comorbidity
1
2013
466
0.020
 Why?
Adolescent
2
2011
2062
0.020
 Why?
Kaplan-Meier Estimate
1
2010
161
0.020
 Why?
Aged
2
2015
8704
0.020
 Why?
Clinical Trials as Topic
1
2007
215
0.020
 Why?
Research Design
1
2007
181
0.020
 Why?
Follow-Up Studies
1
2010
1710
0.020
 Why?
Age Factors
1
2007
742
0.010
 Why?
Calibration
1
2003
16
0.010
 Why?
Reference Standards
1
2003
23
0.010
 Why?
Reaction Time
1
2003
109
0.010
 Why?
Memory, Short-Term
1
2003
99
0.010
 Why?
Electromagnetic Fields
1
2002
8
0.010
 Why?
Psychomotor Performance
1
2003
202
0.010
 Why?
Sensitivity and Specificity
1
2003
485
0.010
 Why?
Motor Activity
1
2003
313
0.010
 Why?
Neuropsychological Tests
1
2003
1223
0.010
 Why?
Dowd's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_